Back
to sessions
Sep 28
Education
EDU 31 - Therapeutic Updates for Rare Genetically Linked Childhood Tumors: ATRT and Malignant Rhabdoid Tumors
MODERATOR(S)
Natia Esiahvili, MD, FASTRO - Emory University
session DESCRIPTION
Atypical teratoid/rhabdoid tumor (ATRT) is a very rare CNS tumor usually occurring in children aged 3 years and younger. Malignant rhabdoid tumors (MRT) commonly start in the kidneys of infants and toddlers, with an average age of diagnosis of 15 months. The session will provide an overview on current therapy of these lesions.
learning objectives
- Discuss the role of radiotherapy in treating MRT and ATRT.
- Detail new systemic therapies for these lesions.
Credits
| AMA PRA Category 1 Credits: | 1.00 |
Presentations
-
05:00pm - 05:02pm ETSpeaker: Natia Esiahvili, MD, FASTRO - Emory University, Atlanta
-
05:02pm - 05:17pm ETSpeaker: Natia Esiahvili, MD, FASTRO - Emory University, Atlanta
-
05:17pm - 05:32pm ETSpeaker: Tom Rosenberg, - Dana Farber Cancer Institute, Boston
-
05:32pm - 05:47pm ETSpeaker: Thomas Merchant, DO, PhD - St. Jude Children's Research Hospital, Memphis
-
05:47pm - 06:00pm ETSpeaker: Natia Esiahvili, MD, FASTRO - Emory University, Atlanta